Redefining Cancer Treatment Through Innovation

Our team of researchers at Encyt Technologies Incorporated believes in outsmarting cancer by understanding its survival tactics. Rather than relying on traditional, broad-spectrum treatments, we focus on how cancer hijacks the body’s healing process to spread. Here’s how our technology helps in fighting metastasis:

Scientists coworkers using digital tablet working in medical research laboratory, analysing biochemicals samples, talking. Scientific lab for medicine, microbiology development with advanced equipment

Arming Doctors With Better Tools

Today's cancer treatment methods often employ a "shotgun" approach because we lack the tools to determine the cancer's next move. Taking advantage of the fact that cancer cells can hijack the body's normal wound healing processes provides us with insight into cancer cell behavior. By studying how cancer cells utilize the inflammatory pathway triggered by our treatments to proliferate and metastasize, we have developed a novel treatment that blocks these pathways to improve current treatments.  

Concentrated chemist african researcher using computer in modern facility. Black healthcare scientist in biochemistry laboratory wearing sterile equipment.

Heading Metastasis Off At The Pass

Encyt research has demonstrated that surgery, chemotherapy and radiation therapies trigger a distinct cytokine response that is expressed within a narrow window of time after treatment. Furthermore, our work has confirmed that a group of distinct cytokines fosters rapid stem cell proliferation and EMT in tissue culture systems. Based on this work, we have focused on blocking these cytokines as a novel treatment for cancer in collaboration with our research partners at the Dr Szewczuk Laboratory at Queen's University, Kingston, Ontario.

 
Encyt Technologies Incorporated

Contact Us

Encyt Technologies Incorporated is committed to giving doctors better tools to fight cancer. If you are interested in learning more about our research, please reach out to us.

Untitled design (9)